In recent years, monocyte to high density lipoprotein cholesterol ratio (MHR) has attracted wide attention as a new marker of inflammatory response. This indicator includes two aspects: inflammatory response and lipid accumulation, which are the two most basic characteristics of Atherosclerosis (AS). AS is closely related to the occurrence of Cardiovascular diseases (CVD). A large number of existing studies have confirmed that MHR is an inflammatory marker that can dynamically reflect the trend of inflammation, can reflect the chronic inflammatory response in blood vessels, and can evaluate the occurrence, development and prognosis of cardiovascular disease in a non-invasive manner. This article reviews recent studies on the role of...
Aim: We aimed to investigate the relationships between metabolic syndrome (MS) and monocyte to high ...
Background and aims Atherogenesis is dependent upon monocyte influx into the vessel wall. In humans,...
2008;28:2071-2077; originally published online July 10, 2008;Arterioscler Thromb Vasc Biol
Inflammation and lipid accumulation are two basic hallmarks of atherosclerosis as a chronic disease....
The monocytes to high-density lipoprotein (HDL)-cholesterol ratio (MHR) indicates inflammation based...
Background. Hypertension poses a major threat to human health, and inflammation is associated with h...
The incidence of lower extremity artery disease (LEAD) has increased worldwide in the last decade. I...
Atherosclerosis is an inflammatory disease which develops very slowly and, in most cases, will not ...
Source of support: Departmental sources Background: High-density lipoprotein (HDL) consists of heter...
Atherosclerosis is a chronic inflammatory disease, in which the immune system has a prominent role i...
High density lipoproteins (HDL) promote the efflux of excess cholesterol from peripheral tissues to ...
Introduction: Stroke is a common neurological condition, with a high incidence of mortality and morb...
BACKGROUND AND PURPOSE: Monocytes and high-density lipoprotein cholesterol (HDL-C) both play importa...
Objectives: The adverse effects of smoking in various pathologies are mediated by its effects on the...
Abstract Background: Assessing the monocyte to high-density lipoprotein ratio (MHR) is a new tool f...
Aim: We aimed to investigate the relationships between metabolic syndrome (MS) and monocyte to high ...
Background and aims Atherogenesis is dependent upon monocyte influx into the vessel wall. In humans,...
2008;28:2071-2077; originally published online July 10, 2008;Arterioscler Thromb Vasc Biol
Inflammation and lipid accumulation are two basic hallmarks of atherosclerosis as a chronic disease....
The monocytes to high-density lipoprotein (HDL)-cholesterol ratio (MHR) indicates inflammation based...
Background. Hypertension poses a major threat to human health, and inflammation is associated with h...
The incidence of lower extremity artery disease (LEAD) has increased worldwide in the last decade. I...
Atherosclerosis is an inflammatory disease which develops very slowly and, in most cases, will not ...
Source of support: Departmental sources Background: High-density lipoprotein (HDL) consists of heter...
Atherosclerosis is a chronic inflammatory disease, in which the immune system has a prominent role i...
High density lipoproteins (HDL) promote the efflux of excess cholesterol from peripheral tissues to ...
Introduction: Stroke is a common neurological condition, with a high incidence of mortality and morb...
BACKGROUND AND PURPOSE: Monocytes and high-density lipoprotein cholesterol (HDL-C) both play importa...
Objectives: The adverse effects of smoking in various pathologies are mediated by its effects on the...
Abstract Background: Assessing the monocyte to high-density lipoprotein ratio (MHR) is a new tool f...
Aim: We aimed to investigate the relationships between metabolic syndrome (MS) and monocyte to high ...
Background and aims Atherogenesis is dependent upon monocyte influx into the vessel wall. In humans,...
2008;28:2071-2077; originally published online July 10, 2008;Arterioscler Thromb Vasc Biol